Retatrutide, from Soma Corp., is attracting significant attention as a innovative treatment for weight management . This dual-action drug combines the mechanism of a GLP-1 receptor agonist and a GIP receptor agonist , aiming to not only promote metabolic improvements but also address related metabolic issues . Initial human data have indicated p… Read More